Literature DB >> 24989455

Growth charts for individuals with Rubinstein-Taybi syndrome.

Lex Beets1, Cristina Rodríguez-Fonseca, Raoul C Hennekam.   

Abstract

Rubinstein-Taybi syndrome (RSTS) is an autosomal dominant disorder characterized by variable degrees of intellectual disability, an unusual face, distal limb anomalies including broad thumbs and broad halluces, a large group of variable other major and minor anomalies, and decreased somatic growth. The aim of the present study was to construct up-to-date growth charts specific for infants and children with RSTS. We collected retrospective growth data of 92 RSTS individuals of different ancestries. Data were corrected for secular trends and population of origin to the Dutch growth charts of 2009. On average, 17.9 measurements were available per individual. Height, weight and body mass index (BMI) references for males and females were constructed using the lambda, mu, sigma method. RSTS individuals had normal birth weight and length. Mean final heights were 162.6 cm [-2.99 standard deviation score (SDS)] for males and 151.0 cm [-3.01 SDS] for females. BMI SDS compared to the general Dutch population were -0.06 and 1.40 SDS for males and females, respectively. Head circumference SDS compared to the general Dutch population was -1.89 SDS for males and -2.71 SDS for females. This is the first study to publish growth charts using only molecularly proven RSTS individuals. These syndrome-specific growth charts can be used in managing problems related to growth in RSTS individuals.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Rubinstein-Taybi syndrome; body mass index; growth charts; microcephaly; short stature

Mesh:

Year:  2014        PMID: 24989455     DOI: 10.1002/ajmg.a.36654

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome.

Authors:  Jean René Cazalets; Emma Bestaven; Emilie Doat; Marie Pierre Baudier; Cécile Gallot; Anouck Amestoy; Manuel Bouvard; Etienne Guillaud; Isabelle Guillain; Emelyne Grech; Julien Van-Gils; Patricia Fergelot; Sonia Fraisse; Emmanuelle Taupiac; Benoit Arveiler; Didier Lacombe
Journal:  J Autism Dev Disord       Date:  2017-11

Review 2.  Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.

Authors:  Silvia Spena; Cristina Gervasini; Donatella Milani
Journal:  J Pediatr Genet       Date:  2015-09-28

3.  Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.

Authors:  Daniela Rusconi; Gloria Negri; Patrizia Colapietro; Chiara Picinelli; Donatella Milani; Silvia Spena; Cinzia Magnani; Margherita Cirillo Silengo; Lorena Sorasio; Vaclava Curtisova; Maria Luigia Cavaliere; Paolo Prontera; Gabriela Stangoni; Giovanni Battista Ferrero; Elisa Biamino; Rita Fischetto; Maria Piccione; Paolo Gasparini; Leonardo Salviati; Angelo Selicorni; Palma Finelli; Lidia Larizza; Cristina Gervasini
Journal:  Hum Genet       Date:  2015-03-25       Impact factor: 4.132

Review 4.  Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.

Authors:  Donatella Milani; Francesca Maria Paola Manzoni; Lidia Pezzani; Paola Ajmone; Cristina Gervasini; Francesca Menni; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2015-01-20       Impact factor: 2.638

5.  Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old.

Authors:  Marco Cipolli; Gloria Tridello; Alessio Micheletto; Sandra Perobelli; Emily Pintani; Simone Cesaro; Emanuela Maserati; Elena Nicolis; Cesare Danesino
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692

6.  The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.

Authors:  Melanie Schoof; Michael Launspach; Dörthe Holdhof; Lynhda Nguyen; Verena Engel; Severin Filser; Finn Peters; Jana Immenschuh; Malte Hellwig; Judith Niesen; Volker Mall; Birgit Ertl-Wagner; Christian Hagel; Michael Spohn; Beat Lutz; Jan Sedlacik; Daniela Indenbirken; Daniel J Merk; Ulrich Schüller
Journal:  Acta Neuropathol Commun       Date:  2019-12-05       Impact factor: 7.801

7.  Clinical description and mutational profile of a Moroccan series of patients with Rubinstein Taybi syndrome.

Authors:  Siham Chafai Elalaoui; Wiam Smaili; Julien Van-Gils; Patricia Fergelot; Ilham Ratbi; Mariam Tajir; Benoit Arveiler; Didier Lacombe; Abdelaziz Sefiani
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

8.  Mowat-Wilson syndrome: growth charts.

Authors:  Ivan Ivanovski; Olivera Djuric; Serena Broccoli; Stefano Giuseppe Caraffi; Patrizia Accorsi; Margaret P Adam; Kristina Avela; Magdalena Badura-Stronka; Allan Bayat; Jill Clayton-Smith; Isabella Cocco; Duccio Maria Cordelli; Goran Cuturilo; Veronica Di Pisa; Juliette Dupont Garcia; Roberto Gastaldi; Lucio Giordano; Andrea Guala; Christina Hoei-Hansen; Mie Inaba; Alessandro Iodice; Jens Erik Klint Nielsen; Vladimir Kuburovic; Brissia Lazalde-Medina; Baris Malbora; Seiji Mizuno; Oana Moldovan; Rikke S Møller; Petra Muschke; Valeria Otelli; Chiara Pantaleoni; Carmelo Piscopo; Maria Luisa Poch-Olive; Igor Prpic; Purificación Marín Reina; Federico Raviglione; Emilia Ricci; Emanuela Scarano; Graziella Simonte; Robert Smigiel; George Tanteles; Luigi Tarani; Aurelien Trimouille; Elvis Terci Valera; Samantha Schrier Vergano; Karin Writzl; Bert Callewaert; Salvatore Savasta; Maria Elisabeth Street; Lorenzo Iughetti; Sergio Bernasconi; Paolo Giorgi Rossi; Livia Garavelli
Journal:  Orphanet J Rare Dis       Date:  2020-06-15       Impact factor: 4.123

Review 9.  Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.

Authors:  Julien Van Gils; Frederique Magdinier; Patricia Fergelot; Didier Lacombe
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

10.  Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome.

Authors:  Naye Choi; Hwa Young Kim; Byung Chan Lim; Jong-Hee Chae; Soo Yeon Kim; Jung Min Ko
Journal:  Mol Genet Genomic Med       Date:  2021-08-24       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.